
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Joseph Araujo, Chief Scientific Officer at Mindset Pharma, sat down to discuss natural vs. synthetic psychedelics.
This month, we spoke with Joseph Araujo, Chief Scientific Officer at Mindset Pharma, to get a better understanding of the differences between natural and synthetic psychedelic medicines. In addition to reviewing the key differences, Araujo also discussed how psychedelics research could signal a shift in how we treat mental health.







